SCHEMBL29340313

SCHEMBL29340313

CNc1cnc2cc(C)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.48
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
EGFR P00533 1/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDGFRB P09619 3/20 0.44
PDGFRA P16234 3/20 0.44
IKBKB O14920 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 2/20 0.39
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29340297 0.92 NQO2 (0.48) NQO2MAPTNPC1EGFRLMNA
SCHEMBL13050378 0.79 PDGFRB (0.41) EGFRPDGFRBPDGFRAALDH1A1KDM4E
SCHEMBL780200 0.79 PABPC1 (0.42) EGFRLMNASMN1; SMN2PDGFRBPDGFRA
SCHEMBL29639043 0.78 CYP1A2 (0.54) NQO2MAPTNPC1EGFRLMNA
SCHEMBL6844954 0.78 CYP1A2 (0.54) NQO2MAPTNPC1EGFRLMNA
SCHEMBL5780177 0.75 PDGFRB (0.62) MAPTNPC1EGFRLMNARAB9A
SCHEMBL19001484 0.74 NQO2 (0.50) NQO2MAPTNPC1EGFRLMNA
SCHEMBL14330664 0.74 NQO2 (0.50) NQO2MAPTNPC1EGFRLMNA
SCHEMBL557898 0.74 ALDH1A1 (0.62) NQO2MAPTNPC1EGFRLMNA
SCHEMBL14239549 0.74 NQO2 (0.50) NQO2MAPTNPC1EGFRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400505-A1 PEPTIDE-UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Bivision Pharmaceuticals, Inc (CN) 2024-07-17 EP disclosed